With the growing demand for resilient, efficient, and low carbon infrastructure, increasing attention has been directed toward novel materials and ...
A key challenge in structure-based drug design is generating three-dimensional molecules while preserving essential protein-ligand interactions. We propose DiffPharma, a structure-based pharmacophore ...
Deep generative modeling has a strong potential to accelerate drug design. However, existing generative models often face challenges in generalization due to limited data, leading to less innovative ...